J. Mizerski

774 total citations
16 papers, 472 citations indexed

About

J. Mizerski is a scholar working on Hepatology, Epidemiology and Infectious Diseases. According to data from OpenAlex, J. Mizerski has authored 16 papers receiving a total of 472 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Hepatology, 12 papers in Epidemiology and 6 papers in Infectious Diseases. Recurrent topics in J. Mizerski's work include Hepatitis C virus research (13 papers), Hepatitis B Virus Studies (11 papers) and HIV/AIDS drug development and treatment (6 papers). J. Mizerski is often cited by papers focused on Hepatitis C virus research (13 papers), Hepatitis B Virus Studies (11 papers) and HIV/AIDS drug development and treatment (6 papers). J. Mizerski collaborates with scholars based in United States, Poland and Belgium. J. Mizerski's co-authors include Étienne Sokal, Maureen M. Jonas, Nancy Little, Kathleen B. Schwarz, Jorge Areias, Isabel Badía, Martin Greensmith, Déirdre Kelly, Stephen D. Gardner and Angela Vegnente and has published in prestigious journals such as New England Journal of Medicine, Hepatology and Journal of Hepatology.

In The Last Decade

J. Mizerski

15 papers receiving 452 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
J. Mizerski United States	6	451	433	46	16	11	16	472
S. Bartolacci Italy	5	398 0.9×	405 0.9×	22 0.5×	14 0.9×	9 0.8×	8	423
Marie Atsama Amougou Cameroon	9	247 0.5×	252 0.6×	64 1.4×	14 0.9×	7 0.6×	12	317
Cheng–Lun Chiang Taiwan	8	376 0.8×	348 0.8×	41 0.9×	15 0.9×	12 1.1×	12	398
R Calzia Italy	6	580 1.3×	546 1.3×	58 1.3×	18 1.1×	5 0.5×	13	605
Zhongping Duan China	4	420 0.9×	363 0.8×	86 1.9×	9 0.6×	5 0.5×	10	446
Naofumi Ohno Japan	8	398 0.9×	383 0.9×	29 0.6×	4 0.3×	3 0.3×	12	426
G. Fiordalisi Italy	7	241 0.5×	219 0.5×	106 2.3×	17 1.1×	10 0.9×	9	336
Fuqiang Cui China	8	231 0.5×	203 0.5×	23 0.5×	9 0.6×	6 0.5×	22	252
Alison Moorat United Kingdom	5	390 0.9×	383 0.9×	69 1.5×	7 0.4×	5 0.5×	6	420
Theodore Ngatchu Italy	6	176 0.4×	151 0.3×	27 0.6×	30 1.9×	5 0.5×	13	209

Countries citing papers authored by J. Mizerski

Since Specialization

Citations

This map shows the geographic impact of J. Mizerski's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J. Mizerski with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J. Mizerski more than expected).

Fields of papers citing papers by J. Mizerski

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J. Mizerski. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J. Mizerski. The network helps show where J. Mizerski may publish in the future.

Co-authorship network of co-authors of J. Mizerski

This figure shows the co-authorship network connecting the top 25 collaborators of J. Mizerski. A scholar is included among the top collaborators of J. Mizerski based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J. Mizerski. J. Mizerski is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

Jonas, Maureen M., Déirdre Kelly, Henry Pollack, et al.. (2012). Efficacy and Safety of Long-term Adefovir Dipivoxil Therapy in Children With Chronic Hepatitis B Infection. The Pediatric Infectious Disease Journal. 31(6). 578–582. 15 indexed citations

Murray, Karen F., Leszek Szenborn, Jacek Wysocki, et al.. (2012). Randomized, placebo-controlled trial of tenofovir disoproxil fumarate in adolescents with chronic hepatitis B. Hepatology. 56(6). 2018–2026. 77 indexed citations

Służewski, Wojciech, Arleta Kowala‐Piaskowska, Jacek Wysocki, et al.. (2012). Treatment of chronic hepatitis C in children with pegylated interferon α2a and ribavirin--a multi-center study.. PubMed. 69(2). 319–26. 4 indexed citations

Jonas, Maureen M., Déirdre Kelly, Henry Pollack, et al.. (2008). Safety, efficacy, and pharmacokinetics of adefovir dipivoxil in children and adolescents (age 2 to <18 years) with chronic hepatitis B. Hepatology. 47(6). 1863–1871. 66 indexed citations

Sokal, Étienne, D. Kelly, Henry Pollack, et al.. (2007). Safety, efficacy and pharmacokinetics of adefovir dipivoxil in children and adolescents (age 2 to < 18) with chronic hepatitis B. Journal of Pediatric Gastroenterology and Nutrition. 44. 28–28. 2 indexed citations

Sokal, Étienne, Déirdre Kelly, J. Mizerski, et al.. (2006). Long-term lamivudine therapy for children with HBeAg-positive chronic hepatitis B. Hepatology. 43(2). 225–232. 87 indexed citations

Sokal, Étienne, D. Kelly, S. Wirth, et al.. (2004). P1202 THE PHARMACOKINETICS (PK) AND SAFETY OF A SINGLE DOSE OF ADEFOVIR DIPIVOXIL (ADV) IN CHILDREN AND ADOLESCENTS (AGED 2–17) WITH CHRONIC HEPATITIS B. Journal of Pediatric Gastroenterology and Nutrition. 39(2). 226–227. 1 indexed citations

Sokal, Étienne, D. Kelly, S. Wirth, et al.. (2004). 445 The pharmacokinetics (PK) and safety of a single dose of adefovir dipivoxil (ADV) in children and adolescents (aged 2–17) with chronic hepatitis B. Journal of Hepatology. 40. 132–132. 4 indexed citations

Sokal, Étienne, J. Mizerski, Marek Woynarowski, et al.. (2003). 1151 An extended, stratified, follow-on study in children with chronic hepatitis B (CHB) who have completed previous lamivudine studies. Hepatology. 38. 710–711. 3 indexed citations

10.

Jonas, Maureen M., J. Mizerski, Isabel Badía, et al.. (2002). Clinical Trial of Lamivudine in Children with Chronic Hepatitis B. New England Journal of Medicine. 346(22). 1706–1713. 197 indexed citations

11.

Kelly, DA, et al.. (2001). A follow-on study in children with chronic hepatitis B (CHB) who completed a placebo controlled lamivudine study - A 6-month interim analysis.. Hepatology. 34(4).

12.

Woynarowski, Marek, et al.. (2001). Interferon + rybavirin vs interferon alone treatment of children with chronic HCV infection. Journal of Hepatology. 34. 139–140. 4 indexed citations

13.

Sokal, Étienne, Deanna L. Kelly, J. Mizerski, et al.. (2001). An international double-blind placebo-controlled trial of lamivudine in 286 children with chronic hepatitis B (CHB). Journal of Hepatology. 34. 23–23. 5 indexed citations

14.

Mizerski, J., Sandra Chartrand, & Kazimiera J. Gajl‐Peczalska. (1981). Con A-induced suppressor cells in man. I. Induction and characterization of suppressor cells. Immunobiology. 158(3). 270–281. 3 indexed citations

15.

Mizerski, J., et al.. (1977). Effect of Methisazone on Immune Response in Mice. Chemotherapy. 23(4). 276–281. 3 indexed citations

16.

Mizerski, J. & Jan‐Peter Sowa. (1975). [Immunoglobulins in chronic liver diseases].. PubMed. 27(2). 187–91. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact